IVF Lite:基于温和卵巢刺激的智能IVF方案用于预后良好患者
单中心前瞻性研究纳入369例首次IVF、女性年龄≤38岁且抗苗勒管激素>1.5 ng/ml和/或FSH≤10 mIU/ml的不孕患者,采用克罗米芬联合重组FSH的固定温和刺激方案,12个月内最多三次胚胎移植,完成方案者累积活产率为64.8%,意向治疗累积活产率为46.8%,无卵巢过度刺激综合征或临床并发症发生。
要点
- 完成IVF Lite方案的369例患者中239例活产,累积活产率64.8%。
- 意向治疗累积活产率为46.8%,自发退出率为4.5%。
- 未发生卵巢过度刺激综合征或临床并发症。
核心结论
- IVF Lite方案对克罗米芬刺激反应良好的预后良好患者有效且安全,耐受性好且促性腺激素用量低,完成方案时三分之二患者获得活产。
研究设计与样本
- 单中心前瞻性研究,纳入首次尝试IVF的不孕患者,女性年龄≤38岁,抗苗勒管激素>1.5 ng/ml和/或FSH≤10 mIU/ml。
- 采用固定方案:月经周期第3至7天每日克罗米芬100 mg,第5、7、9天各150 IU重组FSH;卵泡募集少(少于四个卵泡)时取消周期。
- IVF Lite方案在活产分娩后或12个月内最多三次胚胎移植后视为完成;主要结局为完成方案夫妇的累积活产率。
主要发现
- 共369例患者完成IVF Lite方案,其中239例活产。
- 一次胚胎移植后132例分娩(35.8%),第二次胚胎移植后70例(累积活产率54.7%),第三次尝试后37例(累积活产率64.8%)。
- 未发生卵巢过度刺激综合征或临床并发症。
- 自发退出率为4.5%。
- 意向治疗累积活产率为46.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: The IVF Lite programme is based on mild ovarian stimulation including up to three fresh/frozen embryo transfers within 12 months. Is it effective and safe in good prognosis patients? DESIGN: Single-centre prospective study on infertile patients at their first IVF attempt (female age ≤38 years, anti-Müllerian hormone concentrations >1.5 ng/ml and/or FSH ≤10 mIU/ml). Induction of multiple follicular growth was based on a fixed protocol consisting of clomiphene citrate (100 mg/day) from day 3 to 7 of the menstrual cycle and 150 IU of recombinant FSH on days 5, 7 and 9. In case of low follicular recruitment (fewer than four follicles), the cycle was cancelled. The IVF Lite programme was considered complete after a live birth delivery or up to three embryo transfers within 12 months. The primary outcome was the cumulative live birth rate (cLBR) per couples that completed the programme. RESULTS: A total of 369 patients completed the IVF Lite programme, with 239 live births; 132 patients delivered after one embryo transfer (35.8%), 70 after a second embryo transfer (cLBR 54.7%), and 37 after a third attempt (cLBR 64.8%). No cases of ovarian hyperstimulation syndrome or clinical complications occurred. Spontaneous dropout rate from the programme was 4.5%. The cLBR per intention to treat was 46.8%. CONCLUSIONS: The IVF Lite programme proved to be effective and safe in good prognosis patients with a good response to clomiphene citrate stimulation. It was well tolerated and implied low gonadotrophin consumption. Two-thirds of the patients achieved a live birth at the completion of the programme.
引用
- Gianaroli L, Vitagliano A, Ferraretti AP, et al. IVF Lite: a smart IVF programme based on mild ovarian stimulation for good prognosis patients. Reprod Biomed Online. 2022. PMID: 35610154. doi:10.1016/j.rbmo.2022.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。